Study Title: Phase 2 Study of Gemcitabine, Cisplatin, Quemliclustat (AB680) and Zimberelimab (AB122) during First-Line Treatment of Advanced Biliary Tract Cancers: Big Ten Cancer Research Consortium BTCRC-GI22-564
 

• Open to Accrual at:
  • University of Wisconsin Carbone Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT06048133
• Publications and Presentations:
  • Trials in Progress: ASCO 2024

Study Contact: studies@hoosiercancer.org; (317) 921-2050.